TAM-ing T cells in the tumor microenvironment: implications for TAM receptor targeting
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TAM-ing T cells in the tumor microenvironment: implications for TAM receptor targeting
Authors
Keywords
-
Journal
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-10-31
DOI
10.1007/s00262-019-02421-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immuno-Oncological Efficacy of RXDX-106, a Novel Small Molecule Inhibitor of the TAM (TYRO3, AXL, MER) Family of Kinases
- (2019) Yumi Yokoyama et al. CANCER RESEARCH
- Living on the Edge: Efferocytosis at the Interface of Homeostasis and Pathology
- (2019) Sho Morioka et al. IMMUNITY
- MERTK mediated novel site Akt phosphorylation alleviates SAV1 suppression
- (2019) Yao Jiang et al. Nature Communications
- MERTK Acts as a Costimulatory Receptor on Human CD8+ T Cells
- (2019) Marlies J.W. Peeters et al. Cancer Immunology Research
- Tumor-secreted Pros1 inhibits macrophage M1 polarization to reduce antitumor immune response
- (2018) Eric Ubil et al. JOURNAL OF CLINICAL INVESTIGATION
- The small-molecule MERTK inhibitor UNC2025 decreases platelet activation and prevents thrombosis
- (2018) B. R. Branchford et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Targeting Gas6/TAM in cancer cells and tumor microenvironment
- (2018) Guiling Wu et al. Molecular Cancer
- TAM receptor tyrosine kinases as emerging targets of innate immune checkpoint blockade for cancer therapy
- (2017) Yemsratch T. Akalu et al. IMMUNOLOGICAL REVIEWS
- Growth Arrest-Specific 6 Enhances the Suppressive Function of CD4+CD25+Regulatory T Cells Mainly through Axl Receptor
- (2017) Guang-ju Zhao et al. MEDIATORS OF INFLAMMATION
- Phosphatidylserine Sensing by TAM Receptors Regulates AKT-Dependent Chemoresistance and PD-L1 Expression
- (2017) Canan Kasikara et al. MOLECULAR CANCER RESEARCH
- PD-1 expression on tumor-specific T cells: Friend or foe for immunotherapy?
- (2017) Sylvain Simon et al. OncoImmunology
- Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease and cancer
- (2016) R B Birge et al. CELL DEATH AND DIFFERENTIATION
- UNC2025, a MERTK Small-Molecule Inhibitor, Is Therapeutically Effective Alone and in Combination with Methotrexate in Leukemia Models
- (2016) Deborah DeRyckere et al. CLINICAL CANCER RESEARCH
- The TAM family receptor tyrosine kinase TYRO3 is a negative regulator of type 2 immunity
- (2016) P. Y. Chan et al. SCIENCE
- Targeting the TAM Receptors in Leukemia
- (2016) Madeline Huey et al. Cancers
- The Role of TAM Family Receptors in Immune Cell Function: Implications for Cancer Therapy
- (2016) Magdalena Paolino et al. Cancers
- TAM Receptor Signaling in Immune Homeostasis
- (2015) Carla V. Rothlin et al. Annual Review of Immunology
- Targeted Axl Inhibition Primes Chronic Lymphocytic Leukemia B Cells to Apoptosis and Shows Synergistic/Additive Effects in Combination with BTK Inhibitors
- (2015) S. Sinha et al. CLINICAL CANCER RESEARCH
- MERTK as negative regulator of human T cell activation
- (2015) Raquel Cabezo´n et al. JOURNAL OF LEUKOCYTE BIOLOGY
- AXL Inhibitors in Cancer: A Medicinal Chemistry Perspective
- (2015) Samuel H. Myers et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Mertk receptor tyrosine kinase promotes T–B interaction stimulated by IgD B-cell receptor cross-linking
- (2014) Wen-Hai Shao et al. JOURNAL OF AUTOIMMUNITY
- Receptor Tyrosine Kinases, TYRO3, AXL, and MER, Demonstrate Distinct Patterns and Complex Regulation of Ligand-induced Activation
- (2014) Wen-I Tsou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Mer Receptor Tyrosine Kinase Is Required for the Loss of B Cell Tolerance in the Chronic Graft-versus-Host Disease Model of Systemic Lupus Erythematosus
- (2014) W.-H. Shao et al. JOURNAL OF IMMUNOLOGY
- The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells
- (2014) Magdalena Paolino et al. NATURE
- Diversification of TAM receptor tyrosine kinase function
- (2014) Anna Zagórska et al. NATURE IMMUNOLOGY
- TAM Receptors Support Neural Stem Cell Survival, Proliferation and Neuronal Differentiation
- (2014) Rui Ji et al. PLoS One
- Increased expression of Mer tyrosine kinase in circulating dendritic cells and monocytes of lupus patients: correlations with plasma interferon activity and steroid therapy
- (2014) Brendan A Hilliard et al. ARTHRITIS RESEARCH & THERAPY
- T Cell-Derived Protein S Engages TAM Receptor Signaling in Dendritic Cells to Control the Magnitude of the Immune Response
- (2013) Eugenio A. Carrera Silva et al. IMMUNITY
- Systemic Autoimmunity in TAM Triple Knockout Mice Causes Inflammatory Brain Damage and Cell Death
- (2013) Qiutang Li et al. PLoS One
- Paradoxical role of the proto-oncogene Axl and Mer receptor tyrosine kinases in colon cancer
- (2013) L. Bosurgi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The novel receptor tyrosine kinase Axl is constitutively active in B-cell chronic lymphocytic leukemia and acts as a docking site of nonreceptor kinases: implications for therapy
- (2010) A. K. Ghosh et al. BLOOD
- Potentiating role of Gas6 and Tyro3, Axl and Mer (TAM) receptors in human and murine platelet activation and thrombus stabilization
- (2010) J. M. E. M. COSEMANS et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- The Axl/Gas6 pathway is required for optimal cytokine signaling during human natural killer cell development
- (2008) I.-K. Park et al. BLOOD
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now